{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:02:32Z","timestamp":1768888952536,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.clinbiochem.2012.09.010","type":"journal-article","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T12:46:41Z","timestamp":1347972401000},"page":"155-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Biochemical and molecular diagnosis of tyrosinemia type I with two novel FAH mutations in a Hong Kong chinese patient: Recommendation for expanded newborn screening in Hong Kong"],"prefix":"10.1016","volume":"46","author":[{"given":"Chloe Miu","family":"Mak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-wan","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Chim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tak-shing","family":"Siu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"King-fai","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidney","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2012.09.010_bb0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s100240010146","article-title":"Tyrosinemia: a review","volume":"4","author":"Russo","year":"2001","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.clinbiochem.2012.09.010_bb0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1172\/JCI110809","article-title":"Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone","volume":"71","author":"Sassa","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2012.09.010_bb0015","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1542\/peds.2005-2633I","article-title":"Newborn screening: toward a uniform screening panel and system\u2014executive summary","volume":"117","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinbiochem.2012.09.010_bb0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(92)92685-9","article-title":"Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase","volume":"340","author":"Lindstedt","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2012.09.010_bb0025","first-page":"56","article-title":"Nitisinone: new drug. Type 1 tyrosinemia: an effective drug","volume":"16","year":"2007","journal-title":"Prescrire Int"},{"key":"10.1016\/j.clinbiochem.2012.09.010_bb0030","first-page":"983","article-title":"Analysis of inborn errors of metabolism: disease spectrum for expanded newborn screening in Hong Kong","volume":"124","author":"Lee","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.clinbiochem.2012.09.010_bb0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF01799381","article-title":"Tyrosinaemia type I with normal levels of plasma tyrosine","volume":"13","author":"de Almeida","year":"1990","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.clinbiochem.2012.09.010_bb0040","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.clinbiochem.2004.07.006","article-title":"Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots","volume":"37","author":"Allard","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2012.09.010_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1077558708324299","article-title":"Cost of liver transplantation: a systematic review and meta-analysis comparing the United States with other OECD countries","volume":"66","author":"van der Hilst","year":"2009","journal-title":"Med Care Res Rev"},{"key":"10.1016\/j.clinbiochem.2012.09.010_bb0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1524-4733.2006.00156.x","article-title":"The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model","volume":"10","author":"Cipriano","year":"2007","journal-title":"Value Health"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012005401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012005401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:40:07Z","timestamp":1757864407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912012005401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":10,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0009912012005401"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.09.010","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemical and molecular diagnosis of tyrosinemia type I with two novel FAH mutations in a Hong Kong chinese patient: Recommendation for expanded newborn screening in Hong Kong","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}